Yüksek Risk Grubundaki Genç Kadınlar Için Meme Kanseri Erken Teşhis ve Tarama Sistemi


Şahintürk H., Akduman İ.(Yürütücü)

TÜBİTAK Projesi, 2021 - 2023

  • Proje Türü: TÜBİTAK Projesi
  • Başlama Tarihi: Temmuz 2021
  • Bitiş Tarihi: Temmuz 2023

Proje Özeti

Breast cancer is the most commonly diagnosed cancer in women and has the highest incidence of cancer in women. 1 out

of 8 women is

diagnosed by breast cancer every year. In 2012, it reached 25.2% of women worldwide. The number of patients who were

diagnosed with breast cancer was about 1.7 million worldwide in 2012.

“Early detection is the most possible way with today’s technology to save our wifes, daughters, mothers, …loved ones”

Early diagnosis of cancer is utmost importance and unfortunately the existing solutions on the market have such tremendous

harms on the human body as they mostly use harmful x-ray that there are even academic studies that claim that some

devices even increase the probability of the cancer. X-ray mammography cannot be used as screening tests for women

younger than 40 years old and cannot be used more than one time in a year.

“Early detection is only possible with breast cancer screening of young women early and frequently.”

The breast cancer-screening and diagnosis device that we developed, namely SAFE (Scan And Find Early), is a device

used for imaging tumors in breast tissue using harmless electromagnetic waves without using the X-ray. Our technology is

patented in Turkey and we have already made our EP and PCT patent applications.

“Our disruptive novel SAFE equipment can be used in all ages, as many as required, even in pregnancy”

The initial market segment of SAFE is as an early breast cancer-screening device for women in high-risk breast cancer

group. For that market segment there is no solution other than physical examination by hand.

We have completed a detailed feasibility study and it demonstrates feasibility of introducing